The epidemiology of glioma in adults: a "state of the science" review
Эпидемиология глиом у взрослых: обзор «современного состояния научных знаний»
2014-05-19
SCID: 54.1/p5e45bmx
Discuss with AI
adult glioma epidemiologygenome-wide association studiesglioblastomaglioma biomarkersionizing radiation
Figures from the paper
Abstract (AI)
Gliomas are the most common primary intracranial tumor, representing 81% of malignant brain tumors. Although relatively rare, they cause significant mortality and morbidity. Glioblastoma, the most common glioma histology (∼45% of all gliomas), has a 5-year relative survival of ∼5%. A small portion of these tumors are caused by Mendelian disorders, including neurofibromatosis, tuberous sclerosis, and Li-Fraumeni syndrome. Genomic analyses of glioma have also produced new evidence about risk and prognosis. Recently discovered biomarkers that indicate improved survival include O⁶-methylguanine-DNA methyltransferase methylation, isocitrate dehydrogenase mutation, and a glioma cytosine-phosphate-guanine island methylator phenotype. Genome-wide association studies have identified heritable risk alleles within 7 genes that are associated with increased risk of glioma. Many risk factors have been examined as potential contributors to glioma risk. Most significantly, these include an increase in risk by exposure to ionizing radiation and a decrease in risk by history of allergies or atopic disease(s). The potential influence of occupational exposures and cellular phones has also been examined, with inconclusive results. We provide a “state of the science” review of current research into causes and risk factors for gliomas in adults.
Key Findings
1
A small proportion of adult gliomas arise from Mendelian disorders, including neurofibromatosis, tuberous sclerosis, and Li-Fraumeni syndrome.
2
Evidence linking occupational exposures and cellular-phone use to glioma risk remains inconclusive.
3
Genome-wide association studies identified heritable risk alleles in seven genes associated with increased glioma risk; ionizing radiation increases risk, whereas allergies or atopic disease decrease risk.
4
Glioblastoma represents approximately 45% of gliomas and has an approximately 5% five-year relative survival rate.
5
Gliomas constitute 81% of malignant brain tumors and cause substantial mortality and morbidity despite being relatively rare.
6
MGMT methylation, IDH mutation, and the glioma-CpG island methylator phenotype are biomarkers associated with improved survival.
Research Object
Adult gliomas
Research Subject
Their epidemiology, including causes, risk factors, heritable susceptibility, genomic prognostic biomarkers, and survival-related features
Publication Details
Publication Date
2014-05-19
Journal
Publisher
ISSN
Cited by
2345
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Cited by3
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–20172020
Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment2020
Fully automatic GBM segmentation in the TCGA-GBM dataset: Prognosis and correlation with VASARI features2015